BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Argollo M, Gilardi D, Peyrin-Biroulet C, Chabot JF, Peyrin-Biroulet L, Danese S. Comorbidities in inflammatory bowel disease: a call for action. Lancet Gastroenterol Hepatol 2019;4:643-54. [PMID: 31171484 DOI: 10.1016/S2468-1253(19)30173-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 15.7] [Reference Citation Analysis]
Number Citing Articles
1 Asscher VER, Biemans VBC, Pierik MJ, Dijkstra G, Löwenberg M, van der Marel S, de Boer NKH, Bodelier AGL, Jansen JM, West RL, Haans JJL, van Dop WA, Weersma RK, Hoentjen F, Maljaars PWJ; Dutch Initiative on Crohn and Colitis (ICC) . Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study. Aliment Pharmacol Ther 2020;52:1366-76. [PMID: 32901983 DOI: 10.1111/apt.16073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Kuźnicki P, Neubauer K. Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse. J Clin Med 2021;10:4623. [PMID: 34640641 DOI: 10.3390/jcm10194623] [Reference Citation Analysis]
3 Nass BYS, Dibbets P, Markus CR. Impact of the COVID-19 pandemic on inflammatory bowel disease: The role of emotional stress and social isolation. Stress Health 2021. [PMID: 34273129 DOI: 10.1002/smi.3080] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Guo X, Chong L, Zhang X, Li R. Letter to the editor: Genetically determined IBD is associated with decreased risk of Alzheimer's disease: a Mendelian randomisation study. Gut 2021:gutjnl-2021-325869. [PMID: 34750207 DOI: 10.1136/gutjnl-2021-325869] [Reference Citation Analysis]
5 Asscher VE, Verbiest CM, Waars SN, Mooijaart SP, van der Meulen-de Jong AE, Pieterse AH, Maljaars PJ. Perspectives on Treatment of Inflammatory Bowel Disease in Older Patients: Applying Gut-Feeling in an Evidence-Based Era? EMJ. [DOI: 10.33590/emj/21-00262] [Reference Citation Analysis]
6 Rychter AM, Ratajczak AE, Szymczak-Tomczak A, Michalak M, Eder P, Dobrowolska A, Krela-Kaźmierczak I. Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease. Nutrients 2021;13:1863. [PMID: 34070791 DOI: 10.3390/nu13061863] [Reference Citation Analysis]
7 Wang CY, Chen WL, Cheng-Chung Wei J. Link Between Inflammatory Bowel Disease and Risk of Chronic Kidney Disease. Clin Gastroenterol Hepatol 2021;19:1993-4. [PMID: 33248103 DOI: 10.1016/j.cgh.2020.10.040] [Reference Citation Analysis]
8 Verdugo-Meza A, Ye J, Dadlani H, Ghosh S, Gibson DL. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients 2020;12:E1434. [PMID: 32429195 DOI: 10.3390/nu12051434] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
9 Yu GM, Zhou LF, Liu XM, Liu B, Lai XY, Xu CL, Long MY, Zhu YM, Wang JD, Li MS. Therapeutic effect of indirubin-loaded bovine serum albumin nanoparticules on ulcerative colitis. Biomater Sci 2022. [PMID: 35322266 DOI: 10.1039/d1bm01896e] [Reference Citation Analysis]
10 Rubin KH, Rasmussen NF, Petersen I, Kopp TI, Stenager E, Magyari M, Hetland ML, Bygum A, Glintborg B, Andersen V. Intake of dietary fibre, red and processed meat and risk of late-onset Chronic Inflammatory Diseases: A prospective Danish study on the "diet, cancer and health" cohort. Int J Med Sci 2020;17:2487-95. [PMID: 33029091 DOI: 10.7150/ijms.49314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang HG, Zhang MN, Wen X, He L, Zhang MH, Zhang JL, Yang XZ. Cepharanthine ameliorates dextran sulphate sodium-induced colitis through modulating gut microbiota. Microb Biotechnol 2022. [PMID: 35439340 DOI: 10.1111/1751-7915.14059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Antunes JC, Seabra CL, Domingues JM, Teixeira MO, Nunes C, Costa-Lima SA, Homem NC, Reis S, Amorim MTP, Felgueiras HP. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials (Basel) 2021;11:2035. [PMID: 34443866 DOI: 10.3390/nano11082035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Gao C, Li X, Zhao X, Yang P, Wang X, Chen X, Chen N, Chen F. Standardized studies of the oral microbiome: From technology‐driven to hypothesis‐driven. iMeta 2022;1. [DOI: 10.1002/imt2.19] [Reference Citation Analysis]
14 Wu S, Chen Y, Li Z, Li J, Zhao F, Su X. Towards multi-label classification: Next step of machine learning for microbiome research. Comput Struct Biotechnol J 2021;19:2742-9. [PMID: 34093989 DOI: 10.1016/j.csbj.2021.04.054] [Reference Citation Analysis]
15 Cortes GM, Marcialis MA, Bardanzellu F, Corrias A, Fanos V, Mussap M. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin. Front Microbiol 2022;13:856165. [PMID: 35391730 DOI: 10.3389/fmicb.2022.856165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 El-Ghannam MS, Saad MA, Nassar NN, El-Yamany MF, El-Bahy AAZ. Linagliptin ameliorates acetic acid-induced colitis via modulating AMPK/SIRT1/PGC-1α and JAK2/STAT3 signaling pathway in rats. Toxicol Appl Pharmacol 2022;:115906. [PMID: 35122774 DOI: 10.1016/j.taap.2022.115906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453143 DOI: 10.1038/s41575-021-00492-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
18 Zhang YL, Chen Q, Zheng L, Zhang ZW, Chen YJ, Dai YC, Tang ZP. Jianpi Qingchang Bushen decoction improves inflammatory response and metabolic bone disorder in inflammatory bowel disease-induced bone loss. World J Gastroenterol 2022; 28(13): 1315-1328 [DOI: 10.3748/wjg.v28.i13.1315] [Reference Citation Analysis]
19 Robertson N, Gunn S, Piper R. The Experience of Self-conscious Emotions in Inflammatory Bowel Disease: A Thematic Analysis. J Clin Psychol Med Settings 2021. [PMID: 34950988 DOI: 10.1007/s10880-021-09778-0] [Reference Citation Analysis]
20 Nie K, Yi J, Yang Y, Deng M, Yang Y, Wang T, Chen X, Zhang Z, Wang X. A Broad m6A Modification Landscape in Inflammatory Bowel Disease. Front Cell Dev Biol 2022;9:782636. [DOI: 10.3389/fcell.2021.782636] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kociszewska D, Chan J, Thorne PR, Vlajkovic SM. The Link between Gut Dysbiosis Caused by a High-Fat Diet and Hearing Loss. Int J Mol Sci 2021;22:13177. [PMID: 34947974 DOI: 10.3390/ijms222413177] [Reference Citation Analysis]
22 Ghosh S, Sensky T, Casellas F, Rioux LC, Ahmad T, Márquez JR, Vanasek T, Gubonina I, Sezgin O, Ardizzone S, Kligys K, Petersson J, Suzuki Y, Peyrin-Biroulet L. A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool. J Crohns Colitis 2020:jjaa159. [PMID: 32722760 DOI: 10.1093/ecco-jcc/jjaa159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Wu J, Zhou B, Pang X, Song X, Gu Y, Xie R, Liu T, Xu X, Wang B, Cao H. Clostridium butyricum, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation. Food Funct 2022. [PMID: 35678197 DOI: 10.1039/d2fo00478j] [Reference Citation Analysis]
24 . Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med 2022;386:1766-8. [DOI: 10.1056/nejmc2202778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Chen Y, Chen L, Xing C, Deng G, Zeng F, Xie T, Gu L, Yang H. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol 2020;20:192. [PMID: 32552882 DOI: 10.1186/s12876-020-01339-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ma L, Ni L, Yang T, Mao P, Huang X, Luo Y, Jiang Z, Hu L, Zhao Y, Fu Z, Ni Y. Preventive and Therapeutic Spermidine Treatment Attenuates Acute Colitis in Mice. J Agric Food Chem 2021;69:1864-76. [PMID: 33541082 DOI: 10.1021/acs.jafc.0c07095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Hong C, Chen S, Hsu Y, Yen G. Protective effect of fermented okara on the regulation of inflammation, the gut microbiota, and SCFA production in rats with TNBS-induced colitis. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111390] [Reference Citation Analysis]
28 Swann JW, Koneva LA, Regan-Komito D, Sansom SN, Powrie F, Griseri T. IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors. J Exp Med 2020;217:e20200164. [PMID: 32520308 DOI: 10.1084/jem.20200164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
29 Lo TC, Chen YY, Chen HH. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study. Eye (Lond) 2021. [PMID: 34155367 DOI: 10.1038/s41433-021-01645-4] [Reference Citation Analysis]
30 Aggarwal M, Alkhayyat M, Abou Saleh M, Sarmini MT, Singh A, Garg R, Garg P, Mansoor E, Padival R, Cohen BL. Alzheimer Disease Occurs More Frequently In Patients With Inflammatory Bowel Disease: Insight From a Nationwide Study. J Clin Gastroenterol 2022. [PMID: 35470286 DOI: 10.1097/MCG.0000000000001714] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Jourova L, Satka S, Frybortova V, Zapletalova I, Anzenbacher P, Anzenbacherova E, Hermanova PP, Drabonova B, Srutkova D, Kozakova H, Hudcovic T. Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice. Front Pharmacol 2022;13:936013. [DOI: 10.3389/fphar.2022.936013] [Reference Citation Analysis]